Novartis receives approval for first malaria medicine for newborn babies and young infants
arcticnovartis
Tue, 07/08/2025 – 07:19
Read more about Novartis receives approval for first malaria medicine for newborn babies and young infants
…
Entries by arcticnovartis
Novartis provides update on Phase III GCAptAIN study of Cosentyx® in giant cell arteritis (GCA)
arcticnovartis
Thu, 07/03/2025 – 07:19
Read more about Novartis provides update on Phase III GCAptAIN study of Cosentyx® in giant cell arteritis (GCA)
…
Novartis completes acquisition of Regulus Therapeutics
arcticnovartis
Wed, 06/25/2025 – 15:19
Read more about Novartis completes acquisition of Regulus Therapeutics
Basel, June 25, 2025 – Novartis today announced that it has succes…
Novartis announces expiration of Regulus Therapeutics tender offer
arcticnovartis
Wed, 06/25/2025 – 07:04
Read more about Novartis announces expiration of Regulus Therapeutics tender offer
Basel, June 25, 2025 – Novartis today anno…
Novartis announces expiration of HSR waiting period of Regulus Therapeutics tender offer
arcticnovartis
Mon, 06/23/2025 – 07:04
Read more about Novartis announces expiration of HSR waiting period of Regulus Therapeutics tender offer
…
Novartis Fabhalta® shows statistically significant and clinically meaningful improvements in hemoglobin in new population of patients with PNH
arcticnovartis
Thu, 06/12/2025 – 08:04
Read more about Novartis Fabhalta® shows statistically significan…
Novartis Pluvicto™ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
arcticnovartis
Mon, 06/02/2025 – 07:19
Read more about Novartis Pluvicto™ …
Novartis Kisqali® reduces risk of recurrence in younger patients with early breast cancer in NATALEE subgroup analysis
arcticnovartis
Sun, 06/01/2025 – 15:04
Read more about Novartis Kisqali® reduces risk of recurrence in younger patients with ear…
Novartis announces commencement of tender offer to acquire Regulus Therapeutics
arcticnovartis
Tue, 05/27/2025 – 14:04
Read more about Novartis announces commencement of tender offer to acquire Regulus Therapeutics
Basel, May 27, 2…
New Novartis data at ASCO and EHA showcase momentum of pioneering portfolio with promising pipeline
arcticnovartis
Thu, 05/15/2025 – 15:04
Read more about New Novartis data at ASCO and EHA showcase momentum of pioneering portfolio with promising …